No Data
Truist Raises Price Target on Treace Medical Concepts to $9 From $7, Maintains Hold Rating
Treace Medical Concepts (TMCI) has an average investment rating of hold among analysts polled by Capital IQ, with price targets ranging from $6 to $9.
Express News | Treace Medical Concepts Inc : Truist Securities Raises Target Price to $9 From $7
Treace Medical Concepts Is Maintained at Equal-Weight by Morgan Stanley
Treace Medical Concepts Is Maintained at Equal-Weight by Morgan
Treace Medical Concepts Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 -1.23% Morgan Stanley $5.5 → $8 Maintains Equal-Weight 05/16/2024 -19.75% UBS $16 → $6.5
Express News | Treace Medical Concepts Inc : Morgan Stanley Raises Target Price to $8.00 From $5.50
Morgan Stanley Raises Price Target on Treace Medical Concepts to $8 From $5.50, Keeps Equalweight Rating
Treace Medical Concepts (TMCI) has an average investment rating of hold among analysts polled by Capital IQ, with price targets ranging from $6 to $8.